Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report

被引:2
|
作者
Zino, Leena [1 ,3 ]
Jacobs, Tom G. [1 ]
Nieuwenstein, Thomas [1 ]
Grintjes, Karin [2 ]
Colbers, Angela [1 ]
Burger, David M. [1 ]
机构
[1] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Pharm, Med Ctr, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Internal Med, Med Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Pharm, Med Ctr, 864 Radbou dumc,Geert Grooteplein 10, NL-6525 GA Nijmegen, Netherlands
关键词
KIDNEY-FUNCTION; EXPOSURE;
D O I
10.1097/QAD.0000000000003438
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:363 / 365
页数:3
相关论文
共 50 条
  • [1] Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
    Scott, Rachel K.
    Yu, Yifan
    Marzinke, Mark A.
    Coleman, Jenell S.
    Hendrix, Craig W.
    Bies, Robert
    [J]. FRONTIERS IN REPRODUCTIVE HEALTH, 2023, 5
  • [2] Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
    Plosker, Greg L.
    [J]. DRUGS, 2013, 73 (03) : 279 - 291
  • [3] Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
    Greg L. Plosker
    [J]. Drugs, 2013, 73 : 279 - 291
  • [4] Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection
    Stalter, Randy M.
    Pintye, Jillian
    Mugwanya, Kenneth K.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) : 1367 - 1374
  • [5] Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals
    Jotwani, Vasantha
    Scherzer, Rebecca
    Glidden, David V.
    Mehrotra, Megha
    Defechereux, Patricia
    Liu, Albert
    Gandhi, Monica
    Bennett, Michael
    Coca, Steven G.
    Parikh, Chirag R.
    Grant, Robert M.
    Shlipak, Michael G.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (02) : 169 - 174
  • [6] Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study
    Heron, Jack E.
    McManus, Hamish
    Vickers, Tobias
    Ryan, Kathleen
    Wright, Edwina
    Carter, Allison
    Stoove, Mark
    Asselin, Jason
    Grulich, Andrew
    Donovan, Basil
    Guy, Rebecca
    Varma, Rick
    Chen, Marcus
    Ryder, Nathan
    Lewis, David A.
    Templeton, David J.
    O'Connor, Catherine C.
    Gracey, David M.
    [J]. PLOS ONE, 2023, 18 (02):
  • [7] Tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV prevention in women with osteoporosis: a case report and review of the literature
    Patel, Rupa R.
    Presti, Rachel
    Harrison, Laura C.
    Powderly, William G.
    Chan, Philip A.
    [J]. ANTIVIRAL THERAPY, 2018, 23 (04) : 379 - 382
  • [8] Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
    D'Angelo, Alexa B.
    Westmoreland, Drew A.
    Carneiro, Pedro B.
    Johnson, Jeremiah
    Grov, Christian
    [J]. AIDS PATIENT CARE AND STDS, 2021, 35 (08) : 327 - 334
  • [9] Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?
    Taramasso, Lucia
    Riccardi, Niccolo
    Del Puente, Filippo
    Bruzzone, Bianca
    Ripamonti, Diego
    D'Ambrosio, Beatrice
    Viscoli, Claudio
    Di Biagio, Antonio
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (02) : 168 - 170
  • [10] Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial
    Mandala, Justin
    Nanda, Kavita
    Wang, Meng
    De Baetselier, Irith
    Deese, Jennifer
    Lombaard, Johan
    Owino, Fredrick
    Malahleha, Mookho
    Manongi, Rachel
    Taylor, Douglas
    Van Damme, Lut
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15